On May 12, 2026, we celebrated the inauguration of our second building in Irvine, marking a new milestone in Balt’s development in the United States.
Since establishing our presence in the U.S. market in 2016, Balt has continued to strengthen its industrial and commercial footprint through strategic investments aimed at bringing our medical technologies closer to American patients.
These investments support the creation of highly skilled jobs, the development of advanced manufacturing capabilities, and the strengthening of the U.S. medical innovation ecosystem.
This inauguration reflects our ambition to sustainably pursue our growth across the United States.
This is just the beginning.
Need more information? We are here to help.
